Molecular and clinical response to angiotensin II receptor antagonist in kidney transplant patients with chronic allograft nephropathy
- 1 October 2004
- journal article
- Published by Frontiers Media SA in Transplant International
- Vol. 17 (9) , 540-544
- https://doi.org/10.1111/j.1432-2277.2004.tb00484.x
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Expression of TGF-β and fibrogenic genes in transplant recipients with tacrolimus and cyclosporine nephrotoxicityKidney International, 2002
- Intragraft messenger RNA expression of angiotensinogen: relationship with transforming growth factor beta-1 and chronic allograft nephropathy in kidney transplant patients1Transplantation, 2002
- PROTEINURIA AFTER RENAL TRANSPLANTATION AFFECTS NOT ONLY GRAFT SURVIVAL BUT ALSO PATIENT SURVIVALTransplantation, 2001
- Progression, remission, regression of chronic renal diseasesThe Lancet, 2001
- Transforming growth factor-β and renal graft fibrosisCurrent Opinion in Organ Transplantation, 2000
- INTRAGRAFT EXPRESSION OF TRANSFORMING GROWTH FACTOR-BETA 1 BY A NOVEL QUANTITATIVE REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION ELISA IN LONG LASTING KIDNEY RECIPIENTS1Transplantation, 2000
- Chronic allograft nephropathy: An updateKidney International, 1999
- Losartan decreases plasma levels of TGF-β1 in transplant patients with chronic allograft nephropathyKidney International, 1999
- The Banff 97 working classification of renal allograft pathologyKidney International, 1999
- Angiotensin II stimulates extracellular matrix protein synthesis through induction of transforming growth factor-beta expression in rat glomerular mesangial cells.Journal of Clinical Investigation, 1994